Kamar Sara, Hallit Souheil, Chamandi Souheil
Faculty of Medicine and Medical Sciences, Holy Spirit University of Kaslik (USEK), Jounieh, Lebanon.
INSPECT-LB: National Institute of Public Health, Clinical Epidemiology and Toxicology, Beirut, Lebanon.
BMC Res Notes. 2021 Apr 13;14(1):133. doi: 10.1186/s13104-021-05541-8.
Our study focuses on evaluating the factors associated with vasovagal syncope (VVS) when having a pain procedure at the pain clinic as well as showing variation in vital signs associated with fainting across different periods of the procedure (before, during and after).A retrospective case control study was conducted in a university hospital in Lebanon (CHU-NDS) on adult Lebanese patients with data taken from the archives covering a 4 year period (2016-2019).
The multivariable analysis showed that a higher systolic blood pressure per-procedure was significantly associated with lower odds of having vasovagal syncope. An adequate dose of a vasopressor like ephedrine can be used to prevent a vasovagal event from happening. In our study the blood pressure component was more significant than the heart rate component which stayed in the normal range limit in the three different periods of procedure. Cases having a pain procedure for the first time represent 59.6% of the occurrence of VVS. Vasovagal syncope is a complication that can be prevented in high risk patients. Our study suggests taking preventive measures for VVS for patients with first time infiltration status especially if appearing in an anxious state.
我们的研究重点是评估在疼痛诊所进行疼痛治疗时与血管迷走性晕厥(VVS)相关的因素,并展示在治疗的不同阶段(治疗前、治疗期间和治疗后)与昏厥相关的生命体征变化。在黎巴嫩的一家大学医院(CHU-NDS)对成年黎巴嫩患者进行了一项回顾性病例对照研究,数据取自涵盖4年期间(2016 - 2019年)的档案。
多变量分析表明,每次治疗时较高的收缩压与血管迷走性晕厥的较低发生率显著相关。可以使用适当剂量的血管升压药如麻黄碱来预防血管迷走性事件的发生。在我们的研究中,血压因素比心率因素更显著,心率在治疗的三个不同阶段均保持在正常范围界限内。首次进行疼痛治疗的病例占血管迷走性晕厥发生率的59.6%。血管迷走性晕厥是一种可在高危患者中预防的并发症。我们的研究建议对首次进行浸润治疗的患者采取预防血管迷走性晕厥的措施,特别是如果患者处于焦虑状态。